Skip to main content
Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
105.35
+0.36 (0.34%)
At close: Nov 13, 2026, 4:00 PM EST
106.15
+0.80 (0.76%)
After-hours: Nov 13, 2026, 7:30 PM EST

Oruka Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Nov '26 Dec '25 Dec '24
Market Capitalization
7,1451,467679
Market Cap Growth
423.67%116.22%-
Enterprise Value
5,941971325
Last Close Price
105.3530.3119.39

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Nov '26 Dec '25 Dec '24
PB Ratio
5.933.111.78
P/TBV Ratio
5.983.131.79

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Nov '26 Dec '25 Dec '24
Debt / Equity Ratio
0.000.000.00
Net Debt / Equity Ratio
-1.00-1.01-1.03
Net Debt / EBITDA Ratio
6.583.924.12
Net Debt / FCF Ratio
9.725.406.20
Quick Ratio
28.9621.9228.80
Current Ratio
29.6222.3728.89
Return on Equity (ROE)
-18.12%-24.69%-
Return on Assets (ROA)
-13.15%-17.25%-
Return on Capital Employed (ROCE)
-15.30%-25.80%-24.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Nov '26 Dec '25 Dec '24
Earnings Yield
-2.03%-7.19%-13.46%
FCF Yield
-1.73%-6.03%-9.33%
Buyback Yield / Dilution
-42.31%-171.69%-
SEC Filings: 10-K · 10-Q